POWER OF ATTORNEY

 

 

KNOW ALL PERSONS BY THESE PRESENTS, that I, STUART UNGAR, M.D., hereby constitute and appoint Beverly J. Schafman, Elliott M. Smith and Joel Rubinstein, and each of them, my true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution for me and in my name, place and stead, to sign any Form ID (Uniform Application for Access Codes to File on EDGAR), Schedule 13D or 13G, Form 3 (Initial Statement of Beneficial Ownership of Securities), Form 4 (Statement of Changes in Beneficial Ownership of Securities) and Form 5 (Annual Statement of Beneficial Ownership of Securities) relating to transactions by me in ordinary shares or other securities of Celsus Therapeutics plc and all amendments thereto, and to file the same, with the Securities and Exchange Commission and the appropriate securities exchange, granting unto said attorneys-in-fact and agents, and each of them, or their substitutes, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as I might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, or their substitutes, may lawfully do or cause to be done by virtue hereof. This Power of Attorney shall be effective until such time as I deliver a written revocation thereof to the above-named attorneys-in-fact and agents.

 

 

 

Dated:  September 15, 2015   /s/ Stuart Ungar  
      Stuart Ungar, M.D.  

 

 

 

Akari Therapeutics Plc (NASDAQ:CLTX)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Akari Therapeutics Plc 차트를 더 보려면 여기를 클릭.
Akari Therapeutics Plc (NASDAQ:CLTX)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Akari Therapeutics Plc 차트를 더 보려면 여기를 클릭.